deathligand相关论文
Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinom
BACKGROUND Pulmonary sarcomatoid carcinoma(PSC),a rare subtype of non-small cell lung cancer(NSCLC),is poorly differenti......
BACKGROUND Few studies have addressed the efficacy of pembrolizumab in pulmonary sarcomatoid carcinoma(PSC),a rare,previ......